We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$637M
AUM Growth
+$23.4M
Cap. Flow
+$9.31M
Cap. Flow %
1.46%
Top 10 Hldgs %
11.43%
Holding
348
New
37
Increased
51
Reduced
63
Closed
18

Top Buys

Rank Stock Value
1
EPAM icon
EPAM Systems
EPAM
+$5.99M
2
CF icon
CF Industries
CF
+$3.8M
3
ARRY icon
Array Technologies
ARRY
+$3.17M
4
CC icon
Chemours
CC
+$3.06M
5
MMM icon
3M
MMM
+$2.8M

Top Sells

Rank Stock Value
1
ACLS icon
Axcelis
ACLS
+$3.28M
2
ULTA icon
Ulta Beauty
ULTA
+$3.18M
3
NFLX icon
Netflix
NFLX
+$3.11M
4
AXP icon
American Express
AXP
+$3.09M
5
CRUS icon
Cirrus Logic
CRUS
+$3.02M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 15.69%
3 Consumer Discretionary 14.07%
4 Materials 13.48%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STIM icon
226
Neuronetics
STIM
$166M
$902K 0.14%
+310,000
New +$1.56M
FLWS icon
227
1-800-Flowers.com
FLWS
$258M
$897K 0.14%
78,000
OVV icon
228
Ovintiv
OVV
$16.4B
$895K 0.14%
24,800
OMC icon
229
Omnicom Group
OMC
$23.4B
$877K 0.14%
9,300
-16,700
-64% -$1.48M
SSNC icon
230
SS&C Technologies
SSNC
$18.6B
$875K 0.14%
15,500
-15,500
-50% -$894K
PRLB icon
231
Protolabs
PRLB
$2.13B
$862K 0.14%
26,000
XYZ
232
Block Inc
XYZ
$47.5B
$851K 0.13%
12,400
-3,100
-20% -$232K
ITCI
233
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$839K 0.13%
15,500
FIZZ icon
234
National Beverage
FIZZ
$3.01B
$822K 0.13%
15,600
BJ icon
235
BJs Wholesale Club
BJ
$12.3B
$791K 0.12%
10,400
VISN
236
Vistance Networks Inc
VISN
$2.52B
$790K 0.12%
+124,000
New +$939K
TPH
237
DELISTED
Tri Pointe Homes
TPH
$785K 0.12%
31,000
ALRM icon
238
Alarm.com
ALRM
$2.85B
$779K 0.12%
+15,500
New +$798K
AMAT icon
239
Applied Materials
AMAT
$428B
$762K 0.12%
6,200
-25,000
-80% -$2.87M
BWA icon
240
BorgWarner
BWA
$13.9B
$761K 0.12%
17,608
-17,608
-50% -$729K
CRSP icon
241
CRISPR Therapeutics
CRSP
$5.17B
$751K 0.12%
16,600
EA
242
DELISTED
Electronic Arts
EA
$747K 0.12%
+6,200
New +$728K
TENB icon
243
Tenable Holdings
TENB
$4.01B
$736K 0.12%
15,500
-10,500
-40% -$446K
SWKS icon
244
Skyworks Solutions
SWKS
$10.6B
$731K 0.11%
6,200
-6,200
-50% -$687K
PAAS icon
245
Pan American Silver
PAAS
$21.6B
$728K 0.11%
40,000
+15,000
+60% +$258K
CARR icon
246
Carrier Global
CARR
$52.8B
$709K 0.11%
+15,500
New +$694K
LNC icon
247
Lincoln National
LNC
$8.81B
$697K 0.11%
31,000
CARG icon
248
CarGurus
CARG
$3.47B
$695K 0.11%
37,200
IPI icon
249
Intrepid Potash
IPI
$469M
$684K 0.11%
24,800
CHS
250
DELISTED
Chicos FAS, Inc.
CHS
$677K 0.11%
123,000

Similar funds

Hussman Strategic Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Hussman Strategic Advisors held 348 positions worth $637M, up 3.8% from $614M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Hussman Strategic Advisors's Q1 2023 filing shows 37 new, 51 increased, 63 reduced and 18 closed positions. Its largest new stake was EPAM Systems: 18,600 shares worth $5.56M. The largest sale was Axcelis, an estimated $3.28M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Hussman Strategic Advisors's largest Q1 2023 buy was EPAM Systems: 18,600 shares worth $5.56M.
  • Hussman Strategic Advisors added most to 3M in Q1 2023, an estimated $2.8M increase.
  • Hussman Strategic Advisors's biggest Q1 2023 reduction was Axcelis, cutting an estimated $3.28M.
  • Hussman Strategic Advisors fully exited Seagate in Q1 2023, selling an estimated $2.45M.
  • Hussman Strategic Advisors's ten largest holdings make up 11% of its $637M portfolio in Q1 2023.
  • Hussman Strategic Advisors opened 37 new positions and closed 18 in Q1 2023.
  • Hussman Strategic Advisors's portfolio value rose 3.8% quarter-over-quarter to $637M.

Based on Hussman Strategic Advisors's 13F filing for Q1 2023, filed 5 May 2023.